Table 5. Five Most Prevalent Chronic Condition Triads for US Adults With 3 or More Chronic Conditions, by Sex and Age, National Health Interview Survey, 2010a .
Sex, Age, and Triad | % (95 Confidence Interval) |
---|---|
Men | |
18–44 y | |
Arthritis/diabetes/hypertension | 26.1 (16.70–38.45) |
Asthma/diabetes/hypertension | 15.5 (7.73–28.73)b |
Arthritis/asthma/hypertension | 14.6 (7.17–27.31)b |
Arthritis/COPD/hypertension | 12.2 (6.47–21.79)b |
Arthritis/CHD/hypertension | 7.3 (3.23–15.83)b |
45–64 y | |
Arthritis/diabetes/hypertension | 28.3 (24.34–32.66) |
Arthritis/CHD/hypertension | 17.9 (14.52–21.86) |
CHD/diabetes/hypertension | 14.5 (11.37–18.22) |
Arthritis/cancer/hypertension | 11.2 (8.61–14.53) |
Arthritis/asthma/hypertension | 10.6 (8.03–13.91) |
≥65 y | |
Arthritis/diabetes/hypertension | 28.2 (24.67–32.06) |
Arthritis/cancer/hypertension | 27.5 (23.97–31.31) |
Arthritis/CHD/hypertension | 27.2 (23.43–31.26) |
CHD/diabetes/hypertension | 17.8 (14.66–21.48) |
Cancer/CHD/hypertension | 14.6 (11.82–18.01) |
Women | |
18–44 y | |
Arthritis/asthma/COPD | 24.7 (17.68–33.50) |
Arthritis/asthma/hypertension | 21.3 (15.09–29.09) |
Asthma/COPD/hypertension | 19.8 (13.64–27.89) |
Arthritis/COPD/hypertension | 19.7 (13.82–27.32) |
Arthritis/diabetes/hypertension | 14.4 (9.65–21.03) |
45–64 y | |
Arthritis/diabetes/hypertension | 30.5 (27.24–34.02) |
Arthritis/asthma/hypertension | 22.0 (19.00–25.35) |
Arthritis/COPD/hypertension | 18.4 (15.59–21.52) |
Arthritis/cancer/hypertension | 16.7 (13.80–20.09) |
Arthritis/asthma/COPD | 14.4 (12.08–17.16) |
≥65 y | |
Arthritis/diabetes/hypertension | 32.6 (29.36–35.95) |
Arthritis/cancer/hypertension | 26.9 (23.95–30.13) |
Arthritis/CHD/hypertension | 19.3 (16.44–22.41) |
Arthritis/COPD/hypertension | 16.8 (14.19–19.84) |
Arthritis/asthma/hypertension | 16.5 (13.95–19.38) |
Abbreviations: COPD, chronic obstructive pulmonary disease; CHD, coronary heart disease.
Within triads, chronic conditions are listed in alphabetical order. Arthritis includes arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia.
Relative standard error (RSE) >30% and ≤50% and should be used with caution as they do not meet National Center for Health Statistics standards of reliability and precision.